Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
60
VTRS Quote, Financials, Valuation and Earnings
Last price:
$12.2600
Seasonality move
:
12.21%
Day range:
$12.0020 - $12.4900
52-week range:
$6.8500 - $12.6800
Dividend yield:
3.92%
P/E ratio:
--
P/S ratio:
1.03x
P/B ratio:
0.93x
Volume:
4.2M
Avg. volume:
8.4M
1-year change:
-1.29%
Market cap:
$14.1B
Revenue:
$14.7B
EPS (TTM):
-$3.10
Analysts' Opinion
-
Consensus RatingViatris, Inc. has received a consensus rating of Hold. The company's average rating is a Hold based on 3 Buy ratings, 6 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of $12.1250, Viatris, Inc. has an estimated downside of -0.94% from its current price of $12.2400.
-
Price Target UpsideAccording to analysts, the highest upside price target is $15.0000 representing -100% upside increase from its current price of $12.2400.
Fair Value
-
According to the consensus of 9 analysts, Viatris, Inc. has -0.94% downside to fair value with a price target of $12.1250 per share.
VTRS vs. S&P 500
-
Over the past 5 trading days, Viatris, Inc. has overperformed the S&P 500 by 3.14% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Viatris, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Viatris, Inc. has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Viatris, Inc. reported revenues of $3.8B.
Earnings Growth
-
Viatris, Inc. earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Viatris, Inc. reported earnings per share of -$0.11.
Enterprise value:
27.7B
EV / Invested capital:
0.93x
Price / LTM sales:
1.03x
EV / EBIT:
27.45x
EV / Revenue:
1.97x
PEG ratio (5yr expected):
-0.01x
EV / Free cash flow:
17.17x
Price / Operating cash flow:
8.95x
Enterprise value / EBITDA:
7.32x
Gross Profit (TTM):
$5.3B
Return On Assets:
-9.18%
Net Income Margin (TTM):
-26.25%
Return On Equity:
-21.75%
Return On Invested Capital:
-11.6%
Operating Margin:
8.44%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $15.4B | $15B | $14.1B | $3.8B | $3.8B | |
| Gross Profit | $6.4B | $6.1B | $5.3B | $1.6B | $1.4B | |
| Operating Income | $2.1B | $1.4B | $1B | $489.7M | $317.4M | |
| EBITDA | $5B | $4.2B | $3.8B | $1.2B | $1B | |
| Diluted EPS | $1.51 | -$0.74 | -$3.10 | $0.08 | -$0.11 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $11.3B | $10.5B | $10.9B | $10.7B | $9.3B | |
| Total Assets | $56.1B | $48.7B | $48.7B | $44.8B | $37.9B | |
| Current Liabilities | $10.1B | $6.5B | $6.8B | $7.5B | $7.4B | |
| Total Liabilities | $34.9B | $29.5B | $27.9B | $25B | $22.7B | |
| Total Equity | $21.1B | $19.2B | $20.9B | $19.8B | $15.2B | |
| Total Debt | $23.8B | $19.7B | $18.5B | $15.9B | $14.6B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $2.5B | $2.3B | $2B | $826.5M | $744.9M | |
| Cash From Investing | $904.6M | $2.1B | -$385.2M | $1.7B | -$98.9M | |
| Cash From Financing | -$2.7B | -$3.8B | -$2.5B | -$1.6B | -$228.1M | |
| Free Cash Flow | $2B | $1.9B | $1.6B | $741.1M | $645.2M | |
VTRS
Sector
Market Cap
$14.1B
$28M
Price % of 52-Week High
96.53%
51.03%
Dividend Yield
3.92%
0%
Shareholder Yield
13.08%
-1.54%
1-Year Price Total Return
-1.29%
-17.48%
Beta (5-Year)
0.843
0.518
Dividend yield:
3.92%
Annualized payout:
$0.48
Payout ratio:
16.42%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$11.8700
200-day SMA
Buy
Level
$9.5778
Bollinger Bands (100)
Buy
Level
9.794 - 11.094
Chaikin Money Flow
Buy
Level
21.6M
20-day SMA
Buy
Level
$11.3675
Relative Strength Index (RSI14)
Buy
Level
76.9505
ADX Line
Buy
Level
35.8951
Williams %R
Sell
Level
-14.7929
50-day SMA
Buy
Level
$10.8138
MACD (12, 26)
Buy
Level
3.1698
25-day Aroon Oscillator
Buy
Level
88
On Balance Volume
Neutral
Level
14M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.1006)
Sell
CA Score
(Annual)
Level (-0.4306)
Buy
Beneish M-Score
(Annual)
Level (-2.8252)
Buy
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-1.3077)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Viatris, Inc. is a global healthcare company, which engages in the provision of healthcare and pharmaceutical products. It provides medicines and treatments in various therapeutic areas such as cardiovascular, oncology, dermatology, eye care, gastroenterology, immunology, and women's healthcare. The firm operates through the following segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment consists of operations primarily in North America and Europe. The Greater China segment includes operations in mainland China, Taiwan, and Hong Kong. The JANZ segment covers operations in Japan, Australia, and New Zealand. The Emerging Markets segment encompasses operations in developing markets and emerging economies including in Asia, the Middle East, South and Central America, Africa, and Eastern Europe. The company was founded on February 14, 2019 and is headquartered in Canonsburg, PA.
Stock Forecast FAQ
In the current month, VTRS has received 3 Buy ratings 6 Hold ratings, and 0 Sell ratings. The VTRS average analyst price target in the past 3 months is $12.1250.
-
Where Will Viatris, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Viatris, Inc. share price will drop to $12.1250 per share over the next 12 months.
-
What Do Analysts Say About Viatris, Inc.?
Analysts are divided on their view about Viatris, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Viatris, Inc. is a Sell and believe this share price will rise from its current level to $9.0000.
-
What Is Viatris, Inc.'s Price Target?
The price target for Viatris, Inc. over the next 1-year time period is forecast to be $12.1250 according to 9 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 6 analysts rate the stock a Hold.
-
Is VTRS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Viatris, Inc. is a Hold. 6 of 9 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of VTRS?
You can purchase shares of Viatris, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Viatris, Inc. shares.
-
What Is The Viatris, Inc. Share Price Today?
Viatris, Inc. was last trading at $12.2600 per share. This represents the most recent stock quote for Viatris, Inc.. Yesterday, Viatris, Inc. closed at $12.2400 per share.
-
How To Buy Viatris, Inc. Stock Online?
In order to purchase Viatris, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get VTRS Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
VTRS
Sector
P/E ratio
--
23.89x
PEG ratio
-0.01x
-0.01x
P/B ratio
0.93x
1.82x
Price / LTM sales
1.03x
1.60x
Growth Metrics
VTRS
Sector
Revenue growth
0.13%
4.62%
Earnings growth
-239.37%
10.88%
Revenue (5-year growth)
5.04%
6.5%
Earnings forecast
$0.62
-$0.21
Profitability
VTRS
Sector
Profitability FY 2024
$6.2B
$3.5M
Return on invested capital
-11.6%
-31.77%
Return on assets
-9.18%
-27.96%
Return on equity
-21.75%
-37.63%
Earnings Date
Last Earnings Date
Nov
6
Next Earnings Date
Feb
26
Estimated Next Earnings Date
Feb
5
Balance Sheet
VTRS
Sector
Total cash
$1.1B
$26.3M
Short term investments
$355.1M
$25.7M
Total assets
$41.5B
$78M
Long term debt
$14.6B
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
